Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Q4 2022 Earnings Call Transcript

Operator: Good morning, everyone, and welcome to Deciphera Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Related Keywords

Germany ,New Zealand ,Israel ,Italy ,China ,France ,Spain ,Macau ,Matt Sherman ,Daniel Wolle ,Tucker Kelly ,Margarida Duarte ,Dan Martin ,Steve Hoerter ,Jen Larson ,Head Of International ,Zai Lab ,China National Healthcare Security Administration ,Deciphera Pharmaceuticals Fourth Quarter ,Deciphera Pharmaceuticals Inc ,Nasdaq ,Pfizer ,National Reimbursement Drug List ,Deciphera Pharmaceuticals ,Call Transcript February ,Full Year ,Results Conference ,Senior Vice President ,Chief Executive Officer ,Chief Commercial Officer ,Chief Medical Officer ,Chief Financial ,Private Securities Litigation Reform Act ,Series Session ,Chief Financial Officer ,National Healthcare Security Administration ,Buy For Long Term ,